Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Tanaka

Showing results (381-390 of 443) with videos related to

Pageof 45
Sort By:
Journal of Medicinal Chemistry|April 29, 2005
Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonistsKouji Hattori, Akira Tanaka, Naoaki Fujii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivoNaoki Shimada, Toshihiko Ishii, Teruyoshi Imada, et al.
The Journal of Surgical Research|June 6, 2003
Myoglobin gene expression attenuates hepatic ischemia reperfusion injuryTakashi Nitta, Xu Xundi, Etsuro Hatano, et al.
Molecular Oncology|October 4, 2019
Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activationKenji Tago, Megumi Funakoshi-Tago, Satoshi Ohta, et al.
Journal of Medicinal Chemistry|June 11, 2011
Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptorKazuhiro Miwa, Takenori Hitaka, Takashi Imada, et al.
Lipids in Health and Disease|October 8, 2013
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationaleTakeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 9, 2006
Indirect flow rate estimation of the NEDO PI Gyro pump for chronic BVAD experimentsDaisuke Ogawa, Makoto Yoshizawa, Akira Tanaka, et al.
Neuropsychopharmacology Reports|November 30, 2025
Longitudinal Associations of Serum Orexin-A With Physical Activity and Sleep in Schizophrenia: A Preliminary StudyAkira Tanaka, Yusuke Arai, Takehiko Yasaki, et al.
Hematology (Amsterdam, Netherlands)|September 18, 2012
Clinical features of de novo CD25(+) diffuse large B-cell lymphomaShin-ichiro Fujiwara, Kazuo Muroi, Yuji Hirata, et al.
Optics Express|November 29, 2012
Noncollinear parametric fluorescence by chirped quasi-phase matching for monocycle temporal entanglementAkira Tanaka, Ryo Okamoto, Hwan Hong Lim, et al.
Pageof 45

Showing results (381-390 of 443) with videos related to

Sort By:
Pageof 45
Journal of Medicinal Chemistry|April 29, 2005
Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonistsKouji Hattori, Akira Tanaka, Naoaki Fujii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivoNaoki Shimada, Toshihiko Ishii, Teruyoshi Imada, et al.
The Journal of Surgical Research|June 6, 2003
Myoglobin gene expression attenuates hepatic ischemia reperfusion injuryTakashi Nitta, Xu Xundi, Etsuro Hatano, et al.
Molecular Oncology|October 4, 2019
Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activationKenji Tago, Megumi Funakoshi-Tago, Satoshi Ohta, et al.
Journal of Medicinal Chemistry|June 11, 2011
Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptorKazuhiro Miwa, Takenori Hitaka, Takashi Imada, et al.
Lipids in Health and Disease|October 8, 2013
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationaleTakeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 9, 2006
Indirect flow rate estimation of the NEDO PI Gyro pump for chronic BVAD experimentsDaisuke Ogawa, Makoto Yoshizawa, Akira Tanaka, et al.
Neuropsychopharmacology Reports|November 30, 2025
Longitudinal Associations of Serum Orexin-A With Physical Activity and Sleep in Schizophrenia: A Preliminary StudyAkira Tanaka, Yusuke Arai, Takehiko Yasaki, et al.
Hematology (Amsterdam, Netherlands)|September 18, 2012
Clinical features of de novo CD25(+) diffuse large B-cell lymphomaShin-ichiro Fujiwara, Kazuo Muroi, Yuji Hirata, et al.
Optics Express|November 29, 2012
Noncollinear parametric fluorescence by chirped quasi-phase matching for monocycle temporal entanglementAkira Tanaka, Ryo Okamoto, Hwan Hong Lim, et al.
Pageof 45